Close
ACHEMA MIDDLE EAST 2026
17TH Global Drug Delivery & Formulation Summit 2026

News

      Novo Nordisk Receives FDA Approval Of OZEMPIC® (Semaglutide) Injection For The Treatment Of Adults With Type 2 Diabetes

      FDA Approvals
      Novo Nordisk announced that the U.S. Food and Drug Administration (FDA) approved its New Drug Application (NDA) for OZEMPIC® (semaglutide) injection 0.5 mg or...

      Hitachi Medical Systems Europe Introduces “LISENDO 880”, th New Premium 2D/4D CARDIOVASCULAR Ultrasound System

      Asia
      Premium cardiac and vascular imaging rises to a new standard as Hitachi Medical Systems Europe introduces its new premium 2D/4D cardiovascular ultrasound system, the...

      Canon BioMedical products now available in Austria, Germany, and Switzerland

      Europe
      Canon BioMedical is pleased to announce our latest geographic expansion into the German-speaking countries of Austria, Germany, and Switzerland. We are working with a...

      ChemAxon Software is Integrated into ChemPass’s Novel Drug Design Platform

      Americas
      ChemAxon and ChemPass, jointly announce that several ChemAxon software components and toolkits are incorporated into ChemPass' artificial intelligence design technology platform; and also, into...

      The Great Hall of China: double digit growth at CPhI China

      Asia
      CPhI and P-MEC China , UBM Sinoexpo,CCCMHPIE,Chinese pharmaceutical market development,Asia’s largest pharma event CPhI and P-MEC China, organised by UBM EMEA, UBM Sinoexpo and China...

      Sunovion Receives FDA Approval for Lonhala™ Magnair™ Inhalation Solution to Treat COPD

      FDA Approvals
      Sunovion Pharmaceuticals Inc announced that the U.S. Food and Drug Administration (FDA) approved the New Drug Application (NDA) for Lonhala™ Magnair™ (glycopyrrolate) Inhalation Solution...

      Sanofi’s BRIGHT study comparing Toujeo with insulin degludec meets primary objective

      Europe
      Sanofi's Toujeo met the primary study objective in the first large head-to-head clinical trial, called BRIGHT study, comparing Toujeo with insulin degludec. Sanofi plans...

      Subscribe Our Newsletter

      White Papers

      The Future of Digital Health

      Whitepapers 0
      The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

      Five Best Practices to Deliver Exceptional Multichannel Experiences

      Whitepapers 0
      A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

      The Impact and Use of Social Media in Pharmacovigilance

      Whitepapers 0
      Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...

      About us

      Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and
      comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector. . . Read More

      Resources

      Advertise

      Subscribe

      Copyright © Value Media Group 2026. All rights reserved.